The hemoglobin level at diagnosis was slightly greater in the CDKN2A/B deletion group than in the non-deletion group, indicating that the degree of anemia in these patients was milder than that in the non-deletion group. This evidence concerns the gene CDKN2A and anemia (phenotype).